Bluebird gene therapy shows promise for lethal blood disease

Shares soar after news that four patients were able to forgo life-sustaining blood transfusions after treatment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.